On the Endless Dilemma of Neuroendocrine Neoplasms of the Breast: a Journey Through Concepts and Entities Silvia UccellaGiovanna FinziStefano La Rosa ReviewPaper 02 July 2020 Pages: 321 - 329
Structure, Function, and Morphology in the Classification of Pituitary Neuroendocrine Tumors: the Importance of Routine Analysis of Pituitary Transcription Factors Ozgur MeteSylvia L. Asa BriefCommunication 19 August 2020 Pages: 330 - 336
Stem Cell Transcription Factor Sox2 Is Expressed in a Subset of Folliculo-stellate Cells of Growth Hormone–Producing Pituitary Neuroendocrine Tumours and Its Expression Shows No Association with Tumour Size or IGF1 Levels: a Clinicopathological Study of 109 Cases Jiri SoukupTomáš ČesákFilip Gabalec OriginalPaper 06 July 2020 Pages: 337 - 347
Detection of NTRK1/3 Rearrangements in Papillary Thyroid Carcinoma Using Immunohistochemistry, Fluorescent In Situ Hybridization, and Next-Generation Sequencing Yu-Cheng LeeJui-Yu ChenJen-Fan Hang OriginalPaper 03 September 2020 Pages: 348 - 358
Loss of 5-Hydroxymethylcytosine is an Epigenetic Hallmark of Thyroid Carcinomas with TERT Promoter Mutations Naoki OishiHuy Gia VuongTetsuo Kondo OriginalPaper 15 October 2020 Pages: 359 - 366
Transcription Factor Profiling Identifies Spatially Heterogenous Mediators of Follicular Thyroid Cancer Invasion Norman G. NicolsonJohan O. PaulssonReju Korah OriginalPaper Open access 16 October 2020 Pages: 367 - 376
Correlation of ThyroSeq Results with Surgical Histopathology in Cytologically Indeterminate Thyroid Nodules Patrick D. ChinCatherine Y. ZhuMasha J. Livhits OriginalPaper 15 July 2020 Pages: 377 - 384
Long Noncoding RNA Expression in Adrenal Cortical Neoplasms Oyewale ShiyanbolaHeather HardinRicardo V. Lloyd OriginalPaper 28 July 2020 Pages: 385 - 391
Exploring the Prognostic Role of Ki67 Proliferative Index in Merkel Cell Carcinoma of the Skin: Clinico-Pathologic Analysis of 84 Cases and Review of the Literature Stefano La RosaMatteo BonziniSilvia Uccella OriginalPaper Open access 22 July 2020 Pages: 392 - 400
Clinical Routine Application of the Second-generation Neuroendocrine Markers ISL1, INSM1, and Secretagogin in Neuroendocrine Neoplasia: Staining Outcomes and Potential Clues for Determining Tumor Origin Carl Christofer JuhlinJan ZedeniusAnders Höög OriginalPaper Open access 19 August 2020 Pages: 401 - 410
Long Survival and Prolonged Remission after Surgery and Chemotherapy in a Metastatic Mismatch Repair Deficient Pancreatic Neuroendocrine Carcinoma with MLH1/PMS2 Immunodeficiency and Minimal Microsatellite Shift Alessandro VanoliVittorio PerfettiStefano La Rosa OriginalPaper 09 May 2020 Pages: 411 - 417